US biotech firm Regeneron and its Swiss partner Roche unveiled promising clinical trial results on Monday indicating that an antibody treatment used to treat COVID-19 patients also helps prevent infections.
Check out the full story right here.
Regeneron Antibody Drug Appears Effective Preventing COVID